email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
976 - 990
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Thousand Oaks Bio Completes $235 Million Round for CDMO Ops
$5.00
Available
CARsgen's Claudin18.2 CAR T-Cell Candidate Granted US RMAT Designation
$5.00
Available
Fosun and Insilico Collaborate to Develop Five Candidates
$5.00
Available
Accuredit and N1 Life Form JV to Develop Gene Editing Delivery Technologies
$5.00
Available
Shanghai ZhenGe Completes $100 Million Round for Biologic CDMO Services
$5.00
Available
Sana In-Licenses BCMA CAR Construct from IASO/Innovent in $204 Million Deal
$5.00
Available
Junshi and Coherus Enter $290 Million Agreement for Junshi's TIGIT Antibody
$5.00
Available
Junshi Collaborates With DotBio to Discover Multi-Specific Antibodies
$5.00
Available
Akeso Approved for China Trial of Dual PD-1 Bi-Specifics Therapy
$5.00
Available
Nuance Acquires Sino Health in a Deal Worth at Least $32 Million
$5.00
Available
Clover Bio Starts Construction of R&D Center in Zhangjiang Hi-Tech Park
$5.00
Available
Accro Raises $50 Million for Regulated Cell Death Drug Candidates
$5.00
Available
Jiangsu Atom Closes $45 Million Round for Global Phase III Gout Trial
$5.00
Available
AffaMed Signs $145 Million Agreement for China Rights to Ophthalmic Drug
$5.00
Available
Sperogenix In-licenses Rare Disease Treatment in $124 Million Deal
$5.00
Available